Amryt Earns Wings For Butterfly Skin Drug In Europe
CHMP Recommends Approval Of Filsuvez
CEO Joe Wiley has said the backing of the EMA's advisory committee for its epidermolysis bullosa gel represents "the most significant milestone in Amryt’s history" and is a massive boost for the Dublin-headquartered group after getting a complete response letter in the US a couple of months ago.
